Literature DB >> 20966403

Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice.

Mie Higashimori1, Jeffrey B Tatro, Kathryn J Moore, Michael E Mendelsohn, Jonas B Galper, Debbie Beasley.   

Abstract

OBJECTIVE: Atherosclerosis encompasses a conspicuously maladaptive inflammatory response that might involve innate immunity. Here, we compared the role of Toll-like receptor 4 (TLR4) with that of TLR2 in intimal foam cell accumulation and inflammation in apolipoprotein E (ApoE) knockout (KO) mice in vivo and determined potential mechanisms of upstream activation and downstream action. METHODS AND
RESULTS: We measured lipid accumulation and gene expression in the lesion-prone lesser curvature of the aortic arch. TLR4 deficiency reduced intimal lipid by ≈75% in ApoE KO mice, despite unaltered total serum cholesterol and triglyceride levels, whereas TLR2 deficiency reduced it by ≈45%. TLR4 deficiency prevented the increased interleukin-1α (IL-1α) and monocyte chemoattractant protein-1 mRNA levels seen within lesional tissue, and it also lowered serum IL-1α levels. Smooth muscle cells (SMC) were present within the intima of the lesser curvature of the aortic arch at this early lesion stage, and they enveloped and permeated nascent lesions, which consisted of focal clusters of foam cells. Cholesterol enrichment of SMC in vitro stimulated acyl-coenzyme A:cholesterol acyltransferase-1 mRNA expression, cytoplasmic cholesterol ester accumulation, and monocyte chemoattractant protein-1 mRNA and protein expression in a TLR4-dependent manner.
CONCLUSIONS: TLR4 contributes to early-stage intimal foam cell accumulation at lesion-prone aortic sites in ApoE KO mice, as does TLR2 to a lesser extent. Intimal SMC surround and penetrate early lesions, where TLR4 signaling within them may influence lesion progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20966403      PMCID: PMC3034636          DOI: 10.1161/ATVBAHA.110.210971

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  51 in total

1.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.

Authors:  Y Nakashima; E W Raines; A S Plump; J L Breslow; R Ross
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-05       Impact factor: 8.311

Review 2.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

3.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.

Authors:  L Gu; Y Okada; S K Clinton; C Gerard; G K Sukhova; P Libby; B J Rollins
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

4.  Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis.

Authors:  L Boring; J Gosling; M Cleary; I F Charo
Journal:  Nature       Date:  1998-08-27       Impact factor: 49.962

5.  Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults.

Authors:  S Katsuda; H C Boyd; C Fligner; R Ross; A M Gown
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

6.  Constitutive expression of interleukin-1alpha precursor promotes human vascular smooth muscle cell proliferation.

Authors:  D Beasley; A L Cooper
Journal:  Am J Physiol       Date:  1999-03

7.  Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals.

Authors:  V L Meiner; S Cases; H M Myers; E R Sande; S Bellosta; M Schambelan; R E Pitas; J McGuire; J Herz; R V Farese
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 8.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

Authors:  H C Stary; A B Chandler; S Glagov; J R Guyton; W Insull; M E Rosenfeld; S A Schaffer; C J Schwartz; W D Wagner; R W Wissler
Journal:  Circulation       Date:  1994-05       Impact factor: 29.690

9.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.

Authors:  Kathrin S Michelsen; Michelle H Wong; Prediman K Shah; Wenxuan Zhang; Juliana Yano; Terence M Doherty; Shizuo Akira; Tripathi B Rajavashisth; Moshe Arditi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

10.  Apoptosis and related proteins in different stages of human atherosclerotic plaques.

Authors:  M M Kockx; G R De Meyer; J Muhring; W Jacob; H Bult; A G Herman
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

View more
  51 in total

Review 1.  The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL.

Authors:  Yury I Miller; Soo-Ho Choi; Philipp Wiesner; Yun Soo Bae
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 2.  Atherosclerosis and the role of immune cells.

Authors:  Fulya Ilhan; Sevgi Tas Kalkanli
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

Review 3.  Monocyte and macrophage dynamics during atherogenesis.

Authors:  Klaus Ley; Yury I Miller; Catherine C Hedrick
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

Review 4.  Inflammation-induced foam cell formation in chronic inflammatory disease.

Authors:  Thomas A Angelovich; Anna C Hearps; Anthony Jaworowski
Journal:  Immunol Cell Biol       Date:  2015-03-10       Impact factor: 5.126

5.  Oxidized high density lipoprotein induces macrophage apoptosis via toll-like receptor 4-dependent CHOP pathway.

Authors:  Shutong Yao; Hua Tian; Li Zhao; Jinguo Li; Libo Yang; Feng Yue; Yanyan Li; Peng Jiao; Nana Yang; Yiwei Wang; Xiangjian Zhang; Shucun Qin
Journal:  J Lipid Res       Date:  2016-11-28       Impact factor: 5.922

Review 6.  The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease.

Authors:  Ying Zhou; Peter J Little; Liam Downey; Rizwana Afroz; Yuao Wu; Hang T Ta; Suowen Xu; Danielle Kamato
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-06

7.  Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins.

Authors:  Stephen D Farris; Jie Hong Hu; Ranjini Krishnan; Isaac Emery; Talyn Chu; Liang Du; Michal Kremen; Helén L Dichek; Elizabeth Gold; Stephen A Ramsey; David A Dichek
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

8.  The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice.

Authors:  M Rachel Richards; Audrey S Black; David J Bonnet; Grant D Barish; Connie W Woo; Ira Tabas; Linda K Curtiss; Peter S Tobias
Journal:  Innate Immun       Date:  2012-05-25       Impact factor: 2.680

9.  Impaired innate immune signaling due to combined Toll-like receptor 2 and 4 deficiency affects both periodontitis and atherosclerosis in response to polybacterial infection.

Authors:  Sasanka S Chukkapalli; Sriram Ambadapadi; Kyle Varkoly; Jessica Jiron; Jose Ignacio Aguirre; Indraneel Bhattacharyya; Laurence M Morel; Alexandra R Lucas; Lakshmyya Kesavalu
Journal:  Pathog Dis       Date:  2018-11-01       Impact factor: 3.166

10.  Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts.

Authors:  Luis Villacorta; Lin Chang; Sonia R Salvatore; Tomonaga Ichikawa; Jifeng Zhang; Danica Petrovic-Djergovic; Lingyun Jia; Harald Carlsen; Francisco J Schopfer; Bruce A Freeman; Y Eugene Chen
Journal:  Cardiovasc Res       Date:  2013-01-17       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.